Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
In vivo
EIP Pharma Announces Presentation of Preclinical Data Demonstrating Effects of p38?…
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Newer Targets
Marathon-running molecule could speed up the race for new neurological treatments
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Phase II
Ascendis Pharma Announces Filing of Investigational New Drug (IND) Application for…
Approval
Blueprint Medicines Announces European Medicines Agency Validation of Marketing Authorization Application…
Phase I
Cotinga Pharmaceuticals Releases Additional Interim Data of Phase 1b/2a Combination Trial…
Phase II
InflaRx Reports Additional Analysis of the SHINE Phase IIb Results for…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
Mallinckrodt And Silence Therapeutics Announce Collaboration To Develop And Commercialize RNAi…
Deals
Mallinckrodt To Make An Equity Investment In Silence Therapeutics As Part…
Commercial
Novartis Close to Settling Kickback Lawsuit
Deals
Predictive Oncology Subsidiary Helomics Collaborates with UPMC to Establish a Data…
Home
Clinical
Phase I
Phase I
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Phase I
Cotinga Pharmaceuticals Releases Additional Interim Data of Phase 1b/2a Combination Trial of COTI-2 in Solid Tumors
Firstwordpharma News
-
July 18, 2019
Phase I
Ascentage Pharma announces first patient dosed in Phase I clinical trial of APG-2575 in China as the first China-made Bcl-2 Inhibitor
Phase I
IDEAYA Biosciences Announces First Patient Dosing of PKC inhibitor IDE196 in Phase 1/2 Tissue-Type Agnostic Basket Trial for Solid Tumors Harboring GNAQ or GNA11...
Phase I
4D pharma plc Commences Phase I/II Asthma Trial
Phase I
Emmaus Life Sciences Announces Initiation of its Diverticulosis Study
Phase I
Satsuma Pharmaceuticals Announces Presentation of STS101 (Dihydroergotamine Nasal Powder) Phase 1...
Firstwordpharma News
-
July 8, 2019
0
Phase I
NeuroVive Initiates Second Part of its Ongoing KL1333 Phase Ia/b Clinical...
Biospace News
-
July 4, 2019
0
Phase I
Auris Medical Completes Enrollment of Phase 1b Proof-Of-Concept Trial of AM-201...
Biospace News
-
July 3, 2019
0
Phase I
Unum Therapeutics Announces Regulatory Update from Phase 1 Trial with ACTR087
Firstwordpharma News
-
July 2, 2019
0
Phase I
Neuralstem Announces Publication of Results from Phase 1 Clinical Trial Evaluating...
Firstwordpharma News
-
July 1, 2019
0
1
2
3
...
18
Page 1 of 18
- Advertisement -
MOST POPULAR
Certolizumab Offers 2-Year Durable Response in Treating Plaque Psoriasis: Presented at...
March 8, 2019
Research unlocks biomechanic mystery behind deadly blood clots
April 4, 2019
Mylan’s Wixela becomes first generic of GlaxoSmithKline’s Advair approved in US
January 30, 2019
Eisai Continues Alzheimer’s Research, Adds 2 Alzheimer’s Pros as Execs
May 3, 2019
Load more
HOT NEWS
Gastroenterology
Genkyotex Announces Completion of 24-Week Treatment Period of Its Phase 2...
Deals
MorphoSys and Vivoryon Therapeutics Enter Agreement on Small Molecule Inhibitors of...
Commercial
Valid Insight Wins the Queen’s Most Coveted Award for Enterprise
Immuno-oncology
Kaiku Health and Amgen roll out digital patient support for Multiple...
